Patents by Inventor Lise BERVEN

Lise BERVEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Murill extracts, methods for inhibiting legumain using the same, and methods for treating tumors using the same
    Patent number: 10905728
    Abstract: Extracts of Agaricus blazei Murill have been found to have anti-tumor activity. In particular, a polar, high molecular weight fraction of an Agaricus blazei Murill extract has been found which has an inhibitory effect on legumain activity. Extracts of Agaricus blazei Murill can be used in a pharmaceutical composition to inhibit cysteine protease legumain in a patient suffering from a tumor thereby treating the tumor and preventing new tumors.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: February 2, 2021
    Assignee: Immunopharma AS
    Inventors: Anne Berit Calmeyer Samuelsen, Lise Berven
  • AGARICUS BLAZEI MURILL EXTRACTS, METHODS FOR INHIBITING LEGUMAIN USING THE SAME, AND METHODS FOR TREATING TUMORS USING THE SAME
    Publication number: 20160166623
    Abstract: Extracts of Agaricus blazei Murill have been found to have anti-tumor activity. In particular, a polar, high molecular weight fraction of an Agaricus blazei Murill extract has been found which has an inhibitory effect on legumain activity. Extracts of Agaricus blazei Murill can be used in a pharmaceutical composition to inhibit cysteine protease legumain in a patient suffering from a tumor thereby treating the tumor and preventing new tumors.
    Type: Application
    Filed: December 10, 2015
    Publication date: June 16, 2016
    Applicant: IMMUNOPHARMA AS
    Inventors: Anne Berit Calmeyer SAMUELSEN, Lise BERVEN